Qiming Venture Partners Honored: Investor and Portfolio Founders Named to 36Kr Dark Current Waves 2026 36 Under 36 List

Recently, 36Kr's Waves released its 2026 36 Under 36 list. This year's Under 36 brings together 108 young pioneers spanning AI, hard tech, new energy, and other fields, covering three categories — entrepreneurs, tech innovators, and investors — with a focus on technology-driven industrial transformation and identifying young leaders breaking through in deep-water sectors like AI and hard tech. Qi Hu, Executive Director at Qiming Venture Partners, was selected, along with nine founders from Qiming's portfolio.**

Qi Hu, Executive Director at Qiming Venture Partners

Selected for

2026 36 Under 36 Investors

Cynthia Chen, Chairman, Executive Director and President of Pulnovo Medical

Jinyao Chen, Co-founder and Executive President of Insta360

Luodan Li, Founder and CEO of Xuntu Technology

Xue Li, Founder of Jieti Medical

Tianlan Shao, Founder and CEO of Mech-Mind Robotics

Lixue Xia, Co-founder and CEO of Infinigence AI

Selected for

2026 36 Under 36 Entrepreneurs

Wenchao Ding, Co-founder and Chief Scientist of Tashi Zhihang

Fuli Luo, Head of Xiaomi's MiMo Large Model

Linfeng Zhang, Founder and Chief Scientist of DeepWise

Selected for

2026 36 Under 36 Tech Innovators

36Kr noted that intuition, speed, and a nose for user pain points were once the weapons of business. They still work, but another grammar of entrepreneurship has layered on top. Now, more and more people are coming to the table with papers, models, experimental data, hardware blueprints, and industrial customers. Entrepreneurship is no longer just a competition of business instincts — it has also become a battle over how fast knowledge structures can migrate. The average age of this year's Under 36 honorees is about 33. In terms of education, PhDs and current doctoral students account for more than half of all entrepreneurs and tech innovators, an unprecedented proportion in Under 36 history. On the technology front, AI and robotics combined cover over 70% of honorees. The remaining directions are scattered across new energy, healthcare, quantum computing, and smart vehicles. Nearly half of the selected companies are involved in overseas markets or global expansion in their business operations.

Source | 36Kr

Past Highlights

Qiming Weekly | Top 10 News from Qiming Venture Partners Portfolio Companies Vol.22, 2026.6.30 Qiming Perspectives | Duane Kuang of Qiming Venture Partners: Embrace the Cycle, Cross the Cycle — AI Will Be an Ultra-Long Technology Cycle Qiming Honors | 5 Qiming Venture Partners Investors Named to 2025 Forbes China Midas List

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management of $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have listed on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.

Many Qiming Venture Partners portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 0800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), SinoCellTech (688520.SH), Insilico Medicine (03696.HK), Hope Medicine, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.